Overview
Salma Health runs an integrated brain health platform that combines advanced diagnostics with personalized treatments and ongoing patient support for conditions like depression, anxiety, PTSD, OCD, brain injuries, and Alzheimer's. Its approach starts with precise assessments and follows with treatments such as SAINT neuromodulation, esketamine, Botox for migraines, and infusion therapies, delivered in clinics or via telehealth. Unlike others, it also provides administrative and technology support to the medical practices it partners with, expanding its integrated care network through collaborations like Kaizen Brain Center. Its goal is to establish a science-based standard for connected, coordinated brain healthcare.
Work here?Claim your company
Simplify's take
What believers are saying
- Salma Health opened San Diego, Orange County, Fremont, and Berkeley by February 2026.
- Open roles across clinical operations and growth suggest active hiring in November 2026.
- California virtual care plus in-person clinics broadens access across depression, PTSD, OCD, and dementia.
What critics are saying
- Revenue remains only $1M-$10M as of October 2026, far below expansion ambitions.
- Salma Health depends on narrow, specialist-heavy treatments like SAINT and Spravato reimbursement.
- Big Health, Lark Health, and kaizen-style integrated clinics can compress margins by 2027.
What makes Salma Health unique
- Salma Health raised $80M Series A on February 26, 2026, from ARCH and Mubadala.
- It bundles psychiatry, neurology, SAINT, esketamine, and care coordination under one roof.
- Brain Health OS and clinic-based research differentiate it from standard telepsychiatry practices.
Help us improve and share your feedback! Did you find this helpful?